Livzon Pharmaceutical Group Inc. at its Extraordinary General Meeting of 2022 held on 21 June 2023, approved Election and nomination of Xu Guoxiang, executive director, as non-independent directors, Election and nomination of Huang Jinhua as independent directors and Election of Huang Huamin, Tang Yin as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.41 CNY | -1.20% | +1.44% | +12.57% |
06-06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
06-06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.57% | 4.43B | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. Announces Directorate Appointments